BioCardia

BioCardia rejigs phase 3 heart failure data to find a path forward for cell therapy
Fierce Biotech
Mon, 03/4/24 - 11:43 pm
BioCardia
cell therapy
heart failure
CardiAMP
clinical trials
Myocardial Infarction: Three drug trials to watch in 2024
Clinical Trials Arena
Thu, 02/29/24 - 11:07 am
clinical trials
myocardial infarction
CeleCor
Zalunfiban
BioCardia
CardiAMP
Thrombolytic Science
TS-01
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioSpace
Thu, 09/7/23 - 09:33 am
BioCardia
clinical trials
cell therapy
heart failure
CardiAMP
Biocardia takes a pause for thought
EP Vantage
Tue, 07/25/23 - 10:05 am
BioCardia
CardiAMP
stem cell therapy
heart failure
Bayer’s BlueRock inks cardiovascular cell therapy delivery deal
Fierce Pharma
Wed, 08/31/22 - 10:22 am
Bayer
BlueRock Therapeutics
heart failure
cell therapy
BioCardia
BioCardia Fills in a Key Piece of CardiaAmp Puzzle with New Clearance
Medical Devices and Diagnostics Industry
Mon, 01/20/20 - 10:58 am
BioCardia
CardiAMP
cell therapy
FDA
DNA deflectable guide catheter
BioCardia touts preliminary data from heart failure trial
Drug Delivery Business News
Thu, 08/23/18 - 10:17 pm
BioCardia
devices
heart failure
CardiAMP
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
CP Wire
Mon, 04/9/18 - 09:15 am
BioCardia
CardiAMP
heart failure
clinical trials
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
Mon, 04/9/18 - 09:13 am
BioCardia
CardiAMP
heart failure